Comparison of ESWL Alone and ESWL + Endoscopy for Painful Chronic Pancreatitis
1 other identifier
interventional
50
2 countries
2
Brief Summary
Endoscopy is an established method of treatment for painful obstructive calcified pancreatitis. It involves the disintegration of calcifications using extracorporeal shock wave lithotripsy (ESWL) followed by endoscopic removal of stone fragments possibly associated with stent insertion. A pilot study suggests that ESWL alone relieves pain in calcified chronic pancreatitis (CP). The aim of this study is to compare both techniques in a randomized controlled trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_1
Started Mar 1998
Longer than P75 for phase_1
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 1998
CompletedFirst Submitted
Initial submission to the registry
August 22, 2005
CompletedFirst Posted
Study publicly available on registry
August 24, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 21, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 21, 2022
CompletedMarch 9, 2022
July 1, 2005
24 years
August 22, 2005
February 21, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Relapse of pain at 2 years
Secondary Outcomes (3)
Diameter of the main pancreatic duct at 1 month
Complication rate at 1 month
Treatment-related costs of initial intervention and during follow-up
Interventions
Eligibility Criteria
You may qualify if:
- Painful chronic pancreatitis (\>1 abdominal pain attack during the preceding 12 months)
- At least 1 calcified stone greater than 4 mm in one of its axes in the cephalic or corporeal portion of the main pancreatic duct (MPD) with upstream duct dilation
- Written informed consent obtained from the patient
You may not qualify if:
- History of treatment of the pancreas using ESWL, endoscopy, or surgery
- Pancreatic collection greater than 2 cm in diameter at magnetic resonance or CT scan
- Alkaline phosphatase levels greater than twice the upper limit of normal values or signs of cholangitis
- Age below 18 years
- Pregnancy or lactation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Department of Gastroenterology and Hepatopancretology; Erasme University Hospital
Brussels, 1070, Belgium
Digestive Endoscopy Unit, Department of Surgery, Catholic University
Rome, 00168, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jean-Marc Dumonceau
University Hospital, Geneva
- PRINCIPAL INVESTIGATOR
Jacques Devière
Erasme University Hospital
- PRINCIPAL INVESTIGATOR
Guido Costamagna
Catholic University of Roma
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 22, 2005
First Posted
August 24, 2005
Study Start
March 1, 1998
Primary Completion
February 21, 2022
Study Completion
February 21, 2022
Last Updated
March 9, 2022
Record last verified: 2005-07